鲁抗医药(600789.SH)及控股子公司参与第十一批全国药品集中采购中选

Core Viewpoint - Recently, the National Organization for Drug Procurement Office announced the results of the national centralized drug procurement, in which the company and its subsidiary, Shandong Lukang Pharmaceutical Group Saiter Co., Ltd., have won bids for certain drugs [1] Group 1 - The company, Lukang Pharmaceutical (600789.SH), has been selected in the recent centralized procurement process [1] - The procurement results were published in a notification regarding the national centralized drug procurement (GY-YD2025-1) [1] - The subsidiary involved in the procurement is Shandong Lukang Pharmaceutical Group Saiter Co., Ltd. [1]